Publication | Closed Access

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma

HepatologyRadiation TherapyMedicineAdvanced/unresectable Hepatocellular CarcinomaRandomized TrialLiver CancerLiver TransplantationOncologyRadiation OncologyPhase 1Hepatocellular CarcinomaRadiologyHealth Sciences